Literature DB >> 3316474

Autocrine stimulation of interleukin 1 beta in acute myelogenous leukemia cells.

K Sakai1, T Hattori, M Matsuoka, N Asou, S Yamamoto, K Sagawa, K Takatsuki.   

Abstract

A significant increase in CD25 antigen-positive cells by IL-1 was observed in cells of a patient with M7 acute myelogenous leukemia. Basal proliferation and expression of CD25 antigen by the M7 leukemic cells were inhibited by addition of anti-IL-1 beta antibody in a dose-dependent manner, but not by rabbit anti-IL-1 alpha antibody. Culture supernatants of these leukemic cells contained IL-1 activity, which was specifically inhibited by addition of anti-IL-1 beta antibody, and Northern blot analysis detected intracellular IL-1 beta mRNA. These results indicated that autocrine secretion of IL-1 beta was involved in proliferation of some myelogenous leukemic cells.

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3316474      PMCID： PMC2189653          DOI： 10.1084/jem.166.5.1597

Source DB:  PubMed          Journal:  J Exp Med        ISSN： 0022-1007            Impact factor:   14.307


  16 in total

1.  Megakaryoblastic acute leukemia: identification by the ultrastructural demonstration of platelet peroxidase.

Authors:  J Breton-Gorius; F Reyes; G Duhamel; A Najman; N C Gorin
Journal:  Blood       Date:  1978-01       Impact factor: 22.113

Review 2.  The human hematopoietic colony-stimulating factors.

Authors:  S C Clark; R Kamen
Journal:  Science       Date:  1987-06-05       Impact factor: 47.728

3.  Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group.

Authors:  J M Bennett; D Catovsky; M T Daniel; G Flandrin; D A Galton; H R Gralnick; C Sultan
Journal:  Ann Intern Med       Date:  1985-10       Impact factor: 25.391

4.  A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity.

Authors:  A P Feinberg; B Vogelstein
Journal:  Anal Biochem       Date:  1983-07-01       Impact factor: 3.365

5.  The activity of partially purified leukocytic endogenous mediator in endotoxin-resistant C3H/HeJ mice.

Authors:  R F Kampschmidt; L A Pulliam; H F Upchurch
Journal:  J Lab Clin Med       Date:  1980-04

6.  Cloning, sequence and expression of two distinct human interleukin-1 complementary DNAs.

Authors:  C J March; B Mosley; A Larsen; D P Cerretti; G Braedt; V Price; S Gillis; C S Henney; S R Kronheim; K Grabstein
Journal:  Nature       Date:  1985 Jun 20-26       Impact factor: 49.962

7.  Induction of Tac antigen and proliferation of myeloid leukemic cells by ATL-derived factor: comparison with other agents that promote differentiation of human myeloid or monocytic leukemic cells.

Authors:  S Yamamoto; T Hattori; M Matsuoka; T Ishii; N Asou; M Okada; Y Tagaya; J Yodoi; K Takatsuki
Journal:  Blood       Date:  1986-06       Impact factor: 22.113

8.  T-Cell lymphoma model for the analysis of interleukin 1-mediated T-cell activation.

Authors:  S Gillis; S B Mizel
Journal:  Proc Natl Acad Sci U S A       Date:  1981-02       Impact factor: 11.205

9.  Criteria for the diagnosis of acute leukemia of megakaryocyte lineage (M7). A report of the French-American-British Cooperative Group.

Authors:  J M Bennett; D Catovsky; M T Daniel; G Flandrin; D A Galton; H R Gralnick; C Sultan
Journal:  Ann Intern Med       Date:  1985-09       Impact factor: 25.391

10.  Fluorescent phycobiliprotein conjugates for analyses of cells and molecules.

Authors:  V T Oi; A N Glazer; L Stryer
Journal:  J Cell Biol       Date:  1982-06       Impact factor: 10.539
View more
  13 in total

1.  Overexpression of IL-1 receptor accessory protein in stem and progenitor cells and outcome correlation in AML and MDS.

Authors:  Laura Barreyro; Britta Will; Boris Bartholdy; Li Zhou; Tihomira I Todorova; Robert F Stanley; Susana Ben-Neriah; Cristina Montagna; Samir Parekh; Andrea Pellagatti; Jacqueline Boultwood; Elisabeth Paietta; Rhett P Ketterling; Larry Cripe; Hugo F Fernandez; Peter L Greenberg; Martin S Tallman; Christian Steidl; Constantine S Mitsiades; Amit Verma; Ulrich Steidl
Journal:  Blood       Date:  2012-06-21       Impact factor: 22.113

Review 2.  The role of colony-stimulating factors in acute leukemia.

Authors:  F Herrmann; E Vellenga
Journal:  J Cancer Res Clin Oncol       Date:  1990       Impact factor: 4.553

3.  Cytokine production by a megakaryocytic cell line.

Authors:  B Sandrock; K M Hudson; D E Williams; M A Lieberman
Journal:  In Vitro Cell Dev Biol Anim       Date:  1996-04       Impact factor: 2.416

4.  Expression of ras oncogenes in cultured human cells alters the transcriptional and posttranscriptional regulation of cytokine genes.

Authors:  G D Demetri; T J Ernst; E S Pratt; B W Zenzie; J G Rheinwald; J D Griffin
Journal:  J Clin Invest       Date:  1990-10       Impact factor: 14.808

5.  Identification of Interleukin-1 by Functional Screening as a Key Mediator of Cellular Expansion and Disease Progression in Acute Myeloid Leukemia.

Authors:  Alyssa Carey; David K Edwards; Christopher A Eide; Laura Newell; Elie Traer; Bruno C Medeiros; Daniel A Pollyea; Michael W Deininger; Robert H Collins; Jeffrey W Tyner; Brian J Druker; Grover C Bagby; Shannon K McWeeney; Anupriya Agarwal
Journal:  Cell Rep       Date:  2017-03-28       Impact factor: 9.423

6.  Recombinant human interleukin-1 alpha and recombinant human interleukin-1 beta stimulate cartilage matrix degradation and inhibit glycosaminoglycan synthesis.

Authors:  R J Smith; N A Rohloff; L M Sam; J M Justen; M R Deibel; J C Cornette
Journal:  Inflammation       Date:  1989-08       Impact factor: 4.092

7.  Reduction of inflammation and pyrexia in the rat by oral administration of SDZ 224-015, an inhibitor of the interleukin-1 beta converting enzyme.

Authors:  P R Elford; R Heng; L Révész; A R MacKenzie
Journal:  Br J Pharmacol       Date:  1995-06       Impact factor: 8.739

8.  Antibodies targeting human IL1RAP (IL1R3) show therapeutic effects in xenograft models of acute myeloid leukemia.

Authors:  Helena Ågerstam; Christine Karlsson; Nils Hansen; Carl Sandén; Maria Askmyr; Sofia von Palffy; Carl Högberg; Marianne Rissler; Mark Wunderlich; Gunnar Juliusson; Johan Richter; Kjell Sjöström; Ravi Bhatia; James C Mulloy; Marcus Järås; Thoas Fioretos
Journal:  Proc Natl Acad Sci U S A       Date:  2015-08-10       Impact factor: 11.205

9.  Production of interleukin 1beta by human hematopoietic progenitor cells.

Authors:  K Watari; H Mayani; F Lee; W Dragowska; P M Lansdorp; J W Schrader
Journal:  J Clin Invest       Date:  1996-04-01       Impact factor: 14.808

10.  c-KIT expression enhances the leukemogenic potential of 32D cells.

Authors:  Q Hu; M Trevisan; Y Xu; W Dong; S A Berger; S D Lyman; M D Minden
Journal:  J Clin Invest       Date:  1995-06       Impact factor: 14.808
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.